Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ministry of Health, Saskatchewan | OTHER |
| Merck Frosst Canada Ltd. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Despite proven benefits in reducing morbidity and mortality, many patients become nonadherent to statin therapy within the first year of starting. Due to their accessibility and frequent patient contact, pharmacists are well-positioned to improve medication adherence.
The purpose of this study is to determine whether a simple intervention by community pharmacists can improve statin adherence in new statin users.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pharmacy Intervention Arm | Experimental | All patients receiving statins from pharmacies allocated to the pharmacist intervention arm of the study |
|
| Usual Care | No Intervention | Pharmacies not allocated to the intervention arm will serve as the control. They received no training on the CPATCH intervention and provide usual care to patients at their pharmacy. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CPATCH intervention to support statin adherence | Behavioral | Routine identification of new statin users (first year of therapy), consistent assessment of barriers to adherence at every dispensation for these patients, reassurance about efficacy and safety, and proactive response to identified adherence barriers. |
| Measure | Description | Time Frame |
|---|---|---|
| Mean statin adherence among all eligible new users of statin medications with at least 6 months of follow-up from index prescription | All statin dispensations are captured by the prescription drug plan database. Mean adherence will be measured using the proportion of days covered (sum of days supply for statin prescriptions during study period divided by the number of days of observation). PDC will be adjusted for any days subject was hospitalized during study period., | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of new statin users with adherence greater than or equal to 80% | 6 months | |
| Persistence with statin use among patients with a minimum of 12 months of follow-up | 6 months |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| College of Pharmacy and Nutrition, University of Saskatchewan | Saskatoon | Saskatchewan | S7n 5C9 | Canada |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 20615235 | Background | Evans CD, Eurich DT, Taylor JG, Remillard AJ, Shevchuk YM, Blackburn DF. A pragmatic cluster randomized trial evaluating the impact of a community pharmacy intervention on statin adherence: rationale and design of the Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH) study. Trials. 2010 Jul 8;11:76. doi: 10.1186/1745-6215-11-76. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|